Eine super Chance zum jetzigen Zeitpunkt, ein klarer Kauf! (Seite 23)
eröffnet am 05.02.17 23:15:28 von
neuester Beitrag 20.01.24 13:31:13 von
neuester Beitrag 20.01.24 13:31:13 von
Beiträge: 226
ID: 1.246.190
ID: 1.246.190
Aufrufe heute: 2
Gesamt: 21.247
Gesamt: 21.247
Aktive User: 0
ISIN: US23666P1012 · WKN: A2DU45 · Symbol: DARE
0,4100
USD
0,00 %
0,0000 USD
Letzter Kurs 22:30:00 Nasdaq
Neuigkeiten
| Titel |
|---|
14.05.24 · globenewswire  |
07.05.24 · globenewswire |
02.05.24 · globenewswire |
30.04.24 · globenewswire |
23.04.24 · globenewswire |
Werte aus der Branche Pharmaindustrie
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 3,7500 | +78,57 | |
| 13,100 | +21,07 | |
| 734,80 | +20,00 | |
| 0,5386 | +19,66 | |
| 55,10 | +17,23 |
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 16,100 | -15,26 | |
| 4,0000 | -20,00 | |
| 0,5050 | -20,52 | |
| 0,7500 | -35,34 | |
| 1,0200 | -35,44 |
Beitrag zu dieser Diskussion schreiben
Feedback
Antwort auf Beitrag Nr.: 54.540.350 von Charlie12345 am 15.03.17 14:43:07na sieht heute doch wieder top aus 😀👍
Antwort auf Beitrag Nr.: 54.529.703 von onkelmaddin am 14.03.17 01:31:46Buyout laut den Amis 
Antwort auf Beitrag Nr.: 54.529.028 von Charlie12345 am 13.03.17 21:36:42Cerulean Pharma Inc. (NASDAQ:CERU)
Cerulean Pharma Inc. (NASDAQ:CERU) shares are up over 45% on heavy volume. CERU shares closed at $1.52 on Friday but opened at $1.99 and reached $2.65 before pulling back. While the average daily volume is 1.45 million, CERU shares have traded hands over 15 million times into just the first hour of trading. Extensive research reveals no news has been released on Cerulean Pharma Inc. (NASDAQ:CERU) that could account for the price and volumes increase.
On February 1, 2017 the Board of Directors of Cerulean Pharma Inc. (NASDAQ:CERU) announced that they were seeking “potential alternatives such as the sale of the company, a merger, a business combination, a strategic investment into the company, or a sale, license or disposition of assets of the company.” Such a move would be taken with the aim of increasing shareholder value.
When news of the Board’s decision hit the newswires, traders and investors gapped the shares up. CERU closed at $1.30 that day up from the $0.93 previous close. Could it be that Cerulean Pharma Inc. (NASDAQ:CERU) has found an avenue to a merger or an interested funder? Either event could be a possible avenue to increase shareholder value.
Pre-market trading was heavy for CERU and most of the action was in 100 or 200 lots but there was one trade at 9:29 for 16,585 shares. It is possible that the action was taken by a company insider. In early January, there were three listed trades of more than 14,000 CERU shares by Directors of Cerulean Pharma Inc. (NASDAQ:CERU). The trades were listed as being awarded to the Directors at a share price of $0.77. The CERU lot sizes were 14,935, 24,350, and 16,234. Traders should be on the lookout for any news release confirming any future confirmation of a merger, sale, licensing, or funding.
Cerulean Pharma Inc. (NASDAQ:CERU) shares are up over 45% on heavy volume. CERU shares closed at $1.52 on Friday but opened at $1.99 and reached $2.65 before pulling back. While the average daily volume is 1.45 million, CERU shares have traded hands over 15 million times into just the first hour of trading. Extensive research reveals no news has been released on Cerulean Pharma Inc. (NASDAQ:CERU) that could account for the price and volumes increase.
On February 1, 2017 the Board of Directors of Cerulean Pharma Inc. (NASDAQ:CERU) announced that they were seeking “potential alternatives such as the sale of the company, a merger, a business combination, a strategic investment into the company, or a sale, license or disposition of assets of the company.” Such a move would be taken with the aim of increasing shareholder value.
When news of the Board’s decision hit the newswires, traders and investors gapped the shares up. CERU closed at $1.30 that day up from the $0.93 previous close. Could it be that Cerulean Pharma Inc. (NASDAQ:CERU) has found an avenue to a merger or an interested funder? Either event could be a possible avenue to increase shareholder value.
Pre-market trading was heavy for CERU and most of the action was in 100 or 200 lots but there was one trade at 9:29 for 16,585 shares. It is possible that the action was taken by a company insider. In early January, there were three listed trades of more than 14,000 CERU shares by Directors of Cerulean Pharma Inc. (NASDAQ:CERU). The trades were listed as being awarded to the Directors at a share price of $0.77. The CERU lot sizes were 14,935, 24,350, and 16,234. Traders should be on the lookout for any news release confirming any future confirmation of a merger, sale, licensing, or funding.
Antwort auf Beitrag Nr.: 54.526.715 von onkelmaddin am 13.03.17 16:17:54Es geht weiter schau mal bei stocktwits , Krebsmedi Studie hat voll eingeschlagen
Antwort auf Beitrag Nr.: 54.245.054 von bernd1980 am 05.02.17 23:15:28Heute machts richtig Spaß, mal sehen obs so weiter geht 😀
Trading Spotlight
Es macht richtig Spaß, diese Entwicklung zu beobachten. Hoffentlich geht's so weiter.
Durchsuchen
